PDCD1 and neoplasm: Further immunohistochemistry (IHC) analysis of the tumor environment showed that the number of CD8- and PD-1–positive cells increased significantly in the MC38/mPD-L1 tumor lesion after the PD-L1 blockade treatment; this increase was not observed in MC38/mPD-L1v242.